Location History:
- Vosselaar, BE (2015 - 2016)
- Beerse, BE (2019)
Company Filing History:
Years Active: 2015-2019
Title: Koen Johan Herman Weerts: Innovator in Pharmaceutical Crystallization
Introduction
Koen Johan Herman Weerts is a notable inventor based in Vosselaar, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the area of crystallization processes. With a total of 3 patents to his name, Weerts has demonstrated a commitment to advancing scientific knowledge and improving drug formulations.
Latest Patents
One of his latest patents is titled "Crystallization procedure for obtaining canagliflozin hemihydrate crystals." This invention relates to an improved crystallization procedure that allows for the production of canagliflozin hemihydrate crystals with a narrow particle size distribution. The process involves removing a small part of the crystalline suspension from the crystallization vessel, subjecting it to particle size reduction, and then reintroducing it into the vessel while maintaining a specific temperature range.
Another significant patent is the "Process for the preparation of heterocyclic ester derivatives." This invention focuses on a method for synthesizing heterocyclic ester derivatives that serve as intermediates in the development of protein tyrosine kinase inhibitors, particularly those targeting c-fms kinase.
Career Highlights
Koen Johan Herman Weerts is currently associated with Janssen Pharmaceutica NV, a leading pharmaceutical company known for its innovative research and development. His work at Janssen has allowed him to contribute to important advancements in drug formulation and delivery.
Collaborations
Throughout his career, Weerts has collaborated with several esteemed colleagues, including Alfred Elisabeth Stappers and Christopher A Teleha. These collaborations have further enriched his research and development efforts in the pharmaceutical industry.
Conclusion
Koen Johan Herman Weerts is a distinguished inventor whose work in crystallization processes has the potential to significantly impact the pharmaceutical field. His innovative patents and collaborations reflect his dedication to advancing drug development and improving patient outcomes.